Subscribe To
Exscientia stock surges on merck kgaa partnership
Exscientia PLC shares climbed as much as 30% in pre-market trading on Wednesday after the precision-medicine company announced a new, multi-year coll...
September 20, 2023, 9:13 am
Exscientia's stock rockets toward a record gain after ai-driven drug discovery collaboration with germany's merck kgaa
The U.S.-listed shares of Exscientia PLC EXAI soared 28.5% toward a record one-day gain, and enough to pace all premarket gainers on major U.S. exchan...
September 20, 2023, 7:50 am
Merck: secure a safe 8% annualized return for the next decade
Merck's strong performance in the past two years, driven by Keytruda and Lagevrio, has outperformed the market by an impressive 52%. MRK's acquisition...
September 20, 2023, 4:13 am
Acrivon therapeutics to highlight its acr-368 oncosignature test, used in ongoing phase 2 study to treat patients based on predicted sensitivity to monotherapy with its chk1/2 inhibitor acr-368, at th
WATERTOWN, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clini...
September 19, 2023, 8:32 pm
Cabaletta bio: how long can unique cell therapy developer's sensational bull run continue?
Cabaletta Bio stock has experienced a significant bull run, rising over 2,100% in the past year. The company's focus on autoimmune conditions with a v...
September 19, 2023, 4:56 am
Harpoon therapeutics announces first patients with small cell lung cancer dosed in hpn328 combination cohort
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-...
September 15, 2023, 11:15 am
Nvidia and amgen back ai drug developer generate:biomedicines' $273m financing
Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical and clinical development across ...
September 14, 2023, 11:29 am
Genelux corporation reports inducement grants under nasdaq listing rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-...
September 14, 2023, 11:00 am
Pharmadrug advances investigational cancer therapeutic pd-001 toward in human safety trials
PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) said it continues to advance its patented reformulated enteric-coated version of orally bioavailable cepharanth...
September 14, 2023, 8:56 am
Moderna, inc. (mrna) r&d day and business updates (transcript)
Moderna, Inc. (NASDAQ:MRNA ) R&D Day and Business Updates September 13, 2023 1:00 PM ET Company Participants Stephane Bancel - CEO Stephen Hoge - Pres...
September 14, 2023, 1:29 am
Sensei biotherapeutics to present new preclinical data supporting mechanism of action, pharmacokinetic profile and safety characteristics for sns-101, a conditionally active vista-blocking antibody, a
BOSTON, Sept. 13, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-...
September 13, 2023, 11:30 am
Ideaya's triple threat: melanoma, money, and momentum
IDEAYA Biosciences specializes in precision oncology, has FDA clearance for a Phase 1/2 trial, and part...
September 13, 2023, 6:19 am
Poolbeg pharma talking to potential partners in the oncology arena as it expands scope of key asset
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said is actively in discussions with prospective partners to further explore ...
September 13, 2023, 2:56 am
Io therapeutics, inc., announces publication of data on a novel compound promoting anti-cancer immune responses
SPRING, Texas, Sept. 12, 2023 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., announced today the publication in Scientific Reports – Nature Publishing ...
September 12, 2023, 4:43 am
Pfizer inc. (pfe) management presents at morgan stanley 21st annual global healthcare conference (transcript)
Pfizer Inc. (NYSE:PFE ) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 12:15 PM ET Company Participants Angela Hwang - CCO...
September 11, 2023, 6:04 pm
Medigene ag to present at the baader investment conference 2023
Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-...
September 11, 2023, 12:30 pm
Rosen, trusted investor counsel, encourages rain oncology inc. investors to secure counsel before important september 12 deadline in securities class action – rain
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain ...
September 8, 2023, 10:16 pm
Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13
Management will present and hold virtual 1-on-1 meetings with institutional investors and analysts BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) ...
September 8, 2023, 6:30 pm
Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13
BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compa...
September 8, 2023, 2:30 pm
Imunon to host virtual r&d day on september 14th beginning at 4:00 p.m. et
Program will feature members of IMUNON executive management along with key opinion leaders in immuno-oncology<...
September 7, 2023, 8:30 pm